[1] National Cardiovascular Center. Report on cardiovascular diseases in China, 2014. Beijing: Encyclopedia of China Publishing House. 2015. http://find.nlc.cn/search/showDocDetails?docId=991854239568819400&dataSource=ucs01&query=%E4%B8%AD%E5%9B%BD%E5%BF%83%E8%A1%80%E7%AE%A1%E7%97%85%E6%8A%A5%E5%91%8A2014. (In Chinese)http://find.nlc.cn/search/showDocDetails?docId=991854239568819400&dataSource=ucs01&query=%E4%B8%AD%E5%9B%BD%E5%BF%83%E8%A1%80%E7%AE%A1%E7%97%85%E6%8A%A5%E5%91%8A2014
[2] Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG, Yang WY, et al. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J 2012;33(2):213 − 20. http://dx.doi.org/10.1093/eurheartj/ehr205CrossRef
[3] Wu YF, Huxley R, Li LM, Anna V, Xie GQ, Yao CH, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the china national nutrition and health survey 2002. Circulation 2008;118(25):2679 − 86. http://dx.doi.org/10.1161/CIRCULATIONAHA.108.788166CrossRef
[4] Li YC, Yang L, Wang LM, Zhang M, Huang ZJ, Deng Q, et al. Burden of hypertension in China: a nationally representative survey of 174,621 adults. Int J Cardiol 2017;227:516 − 23. http://dx.doi.org/10.1016/j.ijcard.2016.10.110CrossRef
[5] Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open 2013;3(8):e003423. http://dx.doi.org/10.1136/bmjopen-2013-003423CrossRef
[6] Wang ZW, Chen Z, Zhang LF, Wang X, Hao G, Zhang ZG, et al. Status of hypertension in China: results from the China hypertension survey, 2012−2015. Circulation 2018;137(22):2344 − 56. http://dx.doi.org/10.1161/CIRCULATIONAHA.117.032380CrossRef
[7] Shao S, Hua YC, Yang Y, Liu XJ, Fan JG, Zhang A, et al. Salt reduction in China: a state-of-the-art review. Risk Manag Healthc Policy 2017;10:17 − 28. http://dx.doi.org/10.2147/RMHP.S75918CrossRef
[8] Hipgrave DB, Chang SY, Li XW, Wu YN. Salt and sodium intake in China. JAMA 2016;315(7):703 − 5. http://dx.doi.org/10.1001/jama.2015.15816CrossRef
[9] Tan MQ, He FJ, Wang CQ, MacGregor GA. Twenty-four-hour urinary sodium and potassium excretion in China: a systematic review and meta-analysis. J Am Heart Assoc 2019;8(14):e012923. http://dx.doi.org/10.1161/JAHA.119.012923CrossRef
[10] Wang YF, Xue H, Sun MX, Zhu XY, Zhao L, Yang YX. Prevention and control of obesity in China. Lancet Glob Health 2019;7(9):E1166 − 7. http://dx.doi.org/10.1016/S2214-109X(19)30276-1CrossRef
[11] Chen ZM, Smith M, Du HD, Guo Y, Clarke R, Bian Z, et al. Blood pressure in relation to general and central adiposity among 500 000 adult Chinese men and women. Int J Epidemiol 2015;44(4):1305 − 19. http://dx.doi.org/10.1093/ije/dyv012CrossRef
[12] Wang Y, Wang L, Qu W. New national data show alarming increase in obesity and noncommunicable chronic diseases in China. Eur J Clin Nutr 2017;71(1):149 − 50. http://dx.doi.org/10.1038/ejcn.2016.171CrossRef
[13] Chen XL, Wang YF. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation 2008;117(25):3171 − 80. http://dx.doi.org/10.1161/CIRCULATIONAHA.107.730366CrossRef
[14] Li YP, Jaddoe VW, Qi L, He YN, Lai JQ, Wang JS, et al. Exposure to the Chinese famine in early life and the risk of hypertension in adulthood. J Hypertens 2011;29(6):1085 − 92. http://dx.doi.org/10.1097/HJH.0b013e328345d969CrossRef
[15] Liu LL, Xu XL, Zeng H, Zhang Y, Shi ZM, Zhang F, et al. Increase in the prevalence of hypertension among adults exposed to the Great Chinese Famine during early life. Environ Health Prev Med 2017;22(1):64. http://dx.doi.org/10.1186/s12199-017-0671-2CrossRef
[16] Wu L, Feng XQ, He AX, Ding Y, Zhou XW, Xu ZC. Prenatal exposure to the Great Chinese Famine and mid-age hypertension. PLoS One 2017;12(5):e0176413. http://dx.doi.org/10.1371/journal.pone.0176413CrossRef
[17] Shi ZM, Nicholls SJ, Taylor AW, Magliano DJ, Appleton S, Zimmet P. Early life exposure to Chinese famine modifies the association between hypertension and cardiovascular disease. J Hypertens 2018;36(1):54 − 60. http://dx.doi.org/10.1097/HJH.0000000000001496CrossRef
[18] Zhao LC, Stamler J, Yan LL, Zhou BF, Wu YF, Liu K, et al. Blood pressure differences between northern and southern Chinese: role of dietary factors: the international study on macronutrients and blood pressure. Hypertension 2004;43(6):1332 − 7. http://dx.doi.org/10.1161/01.HYP.0000128243.06502.bcCrossRef
[19] Li SM, Bañuelos GS, Wu LH, Shi WM. The changing selenium nutritional status of Chinese residents. Nutrients 2014;6(3):1103 − 14. http://dx.doi.org/10.3390/nu6031103CrossRef
[20] Liu LP, Lin G, Wang HJ, Zhang B, Du SF. Selenium exposure and incident hypertension among Chinese adults (P24-020-19). Curr Dev Nutr 2019;3(S1):nzz044.P24-020-19. http://dx.doi.org/10.1093/cdn/nzz044.P24-020-19CrossRef
[21] Su L, Jin Y, Unverzagt FW, Liang C, Cheng Y, Hake AM, et al. Longitudinal association between selenium levels and hypertension in a rural elderly Chinese cohort. J Nutr Health Aging 2016;20(10):983 − 8. http://dx.doi.org/10.1007/s12603-016-0700-7CrossRef
[22] Li Q, Hsia J, Yang GH. Prevalence of smoking in China in 2010. N Engl J Med 2011;364(25):2469 − 70. http://dx.doi.org/10.1056/NEJMc1102459CrossRef
[23] Li M, Shi ZM. Dietary pattern during 1991-2011 and its association with cardio metabolic risks in Chinese adults: the china health and nutrition survey. Nutrients 2017;9(11):1218. http://dx.doi.org/10.3390/nu9111218CrossRef
[24] Li YP, Jaddoe VW, Qi L, He YN, Wang D, Lai JQ, et al. Exposure to the chinese famine in early life and the risk of metabolic syndrome in adulthood. Diabetes Care 2011;34(4):1014 − 8. http://dx.doi.org/10.2337/dc10-2039CrossRef
[25] Xian JL, Zeng M, Zhu R, Cai ZJ, Shi ZM, Abdullah AS, et al. Design and implementation of an intelligent monitoring system for household added salt consumption in China based on a real-world study: a randomized controlled trial. Trials 2020;21(1):349. http://dx.doi.org/10.1186/s13063-020-04295-1CrossRef
[26] The Ministry of Health. China national plan for NCD prevention and treatment (2012-2015). http://www.chinacdc.cn/en/ne/201207/t20120725_64430.html. (2012-5-8).http://www.chinacdc.cn/en/ne/201207/t20120725_64430.html
[27] Guan YQ, Zhang M, Zhang X, Zhao ZP, Huang ZJ, Li C, et al. Hypertension prevalence, awareness, treatment, control, and associated factors in the labor force population — China, 0215. China CDC Wkly 2020;2(10):147 − 55. http://dx.doi.org/10.46234/ccdcw2020.040CrossRef